RhumbLine Advisers
ONEM

RhumbLine Advisers’s 1Life Healthcare ONEM Stock Holding History

RhumbLine Advisers’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-323,196
Closed -$5.4M – 2986
2022
Q4 		$5.4M Buy
323,196
+17,917
+6% +$303K 0.01% 1238
2022
Q3 		$5.24M Buy
305,279
+38,475
+14% +$604K 0.01% 1204
2022
Q2 		$2.09M Buy
266,804
+139,335
+109% +$1.2M ﹤0.01% 1746
2022
Q1 		$1.41M Buy
127,469
+3,448
+3% +$38.6K ﹤0.01% 1981
2021
Q4 		$2.18M Buy
124,021
+1,980
+2% +$38.4K ﹤0.01% 1831
2021
Q3 		$2.47M Buy
122,041
+4,903
+4% +$126K ﹤0.01% 1780
2021
Q2 		$3.87M Buy
117,138
+33,234
+40% +$1.25M 0.01% 1574
2021
Q1 		$3.28M Sell
83,904
-13,036
-13% -$612K ﹤0.01% 1647
2020
Q4 		$4.23M Buy
96,940
+10,156
+12% +$347K 0.01% 1457
2020
Q3 		$2.46M Buy
86,784
+55,563
+178% +$1.75M ﹤0.01% 1559
2020
Q2 		$1.13M Buy
31,221
+7,032
+29% +$198K ﹤0.01% 1993
2020
Q1 		$439K Buy
+24,189
New +$530K ﹤0.01% 2226

RhumbLine Advisers's ONEM Position: Q1 2023 in Review

RhumbLine Advisers sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 323,196 shares — an estimated $5.4M sold.

RhumbLine Advisers first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $5.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • RhumbLine Advisers reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 323,196 1Life Healthcare shares in Q1 2023, an estimated $5.4M.
  • RhumbLine Advisers first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • RhumbLine Advisers's 1Life Healthcare position peaked at $5.4M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.